Evidence map›Paper›PMID 17014383›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2007

Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells.

Kristen L Shogren, Russell T Turner, Michael J Yaszemski, Avudaiappan Maran

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.Journal of experimental & clinical cancer research : CR · 2018
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kristen L ShogrenDepartment of Orthopedics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Russell T Turner
Michael J Yaszemski
Avudaiappan Maran
Mayo Clinic · USOregon State University · US

Funding

DOSE RESPONSE EFFECTS OF ALCOHOL ON BONE METABOLISMR01AA011140 · NIAAA · OREGON STATE UNIVERSITY · PI TURNER, RUSSELL THOMAS · 1996 to 2006
$1.8M
Estrogen Metabolites in the Control of OsteosarcomaR03CA102878 · NCI · MAYO CLINIC · PI MARAN, AVUDAIAPPAN · 2004 to 2005
$148k
SPINAL BENDING MOTIONS FOR PREVENTING DISC DEGENERATIONF32AR048033 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HSIEH, ADAM H · 2001 to 2003
$127k
NCI NIH HHS CA 10287801-A1NCI NIH HHS R03 CA102878NIAAA NIH HHS AA 011140NIAAA NIH HHS R01 AA011140NIAMS NIH HHS AR 48033NIAMS NIH HHS F32 AR048033
6 · The paper itself

Abstract

unlabelledWe studied the involvement of interferon-regulated, PKR on 2-ME-mediated actions in human osteosarcoma cells. Our results show that PKR is activated by 2-ME treatment and is necessary for 2-ME-mediated induction of osteosarcoma cell death.

introductionOsteosarcoma is the most common primary bone tumor and most frequently develops during adolescence. 2-Methoxyestradiol (2-ME), a metabolite of 17beta-estradiol, induces interferon gene expression and apoptosis in human osteosarcoma cells. In this report, we studied the role of interferon-regulated double-stranded (ds)RNA-dependent protein kinase (PKR) protein on 2-ME-mediated cell death in human osteosarcoma cells. MATERIALS AND

methodsWestern blot analyses were used to measure PKR protein and phosphorylation levels. Cell survival and apoptosis assays were measured using trypan blue exclusion and Hoechst dye methods, respectively. A transient transfection protocol was used to express the dominant negative PKR mutants. RESULTS AND

conclusionsPKR was increased in 2-ME-treated MG63 cells, whereas 17beta-estradiol, 4-hydroxyestradiol, and 16alpha-hydroxyestradiol, which do not induce cell death, had no effect on PKR protein levels. Also, 2-ME treatment induced PKR kinase activity as indicated by increased autophosphorylation and phosphorylation of the endogenous substrate, eukaryotic initiation factor (eIF)-2alpha. dsRNA poly (I).poly (C), an activator of PKR protein, increased cell death when osteosarcoma cells were treated with a submaximal concentration of 2-ME. In contrast, a serine-threonine kinase inhibitor SB203580 and a specific PKR inhibitor 2-aminopurine (2-AP) blocked the 2-ME-induced cell death in MG63 cells. A dominant negative PKR mutant protein conferred resistance to 2-ME-induced cell death to MG63 osteosarcoma and 2-ME-mediated PKR regulation did not require interferon gene expression. PKR protein is activated in cell free extracts by 2-ME treatment, resulting in autophosphorylation and in the phosphorylation of the substrate eIF-2alpha. We conclude from these results that PKR is regulated by 2-ME independently of interferon and is essential for 2-ME-mediated cell death in MG63 osteosarcoma cells.

Indexed as

Bone NeoplasmsOsteosarcoma2-MethoxyestradiolApoptosisCell DeathCell DivisionCell Line, TumorEstradiolHumansProtein Kinase InhibitorsProtein KinasesRNA, Double-Stranded2-MethoxyestradiolEstradiolProtein Kinase InhibitorsProtein KinasesRNA, Double-Stranded

Identifiers

PMID17014383
PMCPMC1955766
OpenAlexW2008795703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.